Christopher Thorn

Mr. Thorn is Chief Financial Officer of Équilibre Biopharmaceuticals Corp where he leads the company’s financial reporting, accounting, and related internal controls functions. Prior to Équilibre, Mr. Thorn served as Corporate Controller for Dragados USA Inc., a leading construction brand of the ACS Group. Previously, Mr. Thorn served as Controller of Turing Pharmaceuticals and Vice-President and Controller of Kadmon, both biopharmaceutical organizations with commercial and research operations. Mr. Thorn began his career with KPMG in the audit practice, serving clients in the consumer and industrial markets.

Mr. Thorn received a Bachelor of Science in Accounting and a Master’s of Business Administration in Public Accounting from St. John’s University and is a certified public accountant in the State of New York.